Nemaura Medical, Inc. · OTC:NMRD

Nemaura Medical — Investor Presentation (July 2020)

11 slides from Nemaura Medical's investor presentation, Jul 14, 2020

  1. Slide 1: Better Diagnostics for Life: BEAT Continuous non-invasive Lactate Monitoring

    Better Diagnostics for Life BEAT™ Continuous non - invasive Lactate Monitoring In Critical Care and Monitoring Disease Progression in Covid - 19 July 2020

  2. Slide 2: Author Dr Moiz Khan, Pharm.D, MBA

    2 Author Dr Moiz Khan, Pharm.D , MBA

  3. Slide 3: Overview

    3 Overview Continuous Lactate monitoring has Potential in Medical and non Medical Applications. Medical Field - Recent reports of elevated Lactate levels in Covid - 19 patients - Critical Care monitoring Non - Medical Field - Athletic performance monitoring/endurance training This presentation highl

  4. Slide 4: Increased blood lactate levels: a marker of critical disease states

    4 Increased blood lactate levels: a marker of critical disease states Normal blood lactate levels are 1.3 mmol /L . Lactate metabolism mainly occurs in the liver and kidney. Increased lactate levels have been consistently associated with morbidity and mortality in a wide range of disease states for

  5. Slide 5: Clinical use of lactate monitoring in critically ill patients

    5 Clinical use of lactate monitoring in critically ill patients Increased blood lactate levels ( hyperlactataemia ) is common in critically ill patients. Lactate levels are frequently used to diagnose inadequate tissue oxygenation, and other processes not related to tissue oxygenation may also incre

  6. Slide 6: Clinical applications of lactate testing in patients with sepsis and septic shock

    6 Clinical applications of lactate testing in patients with sepsis and septic shock Hyperlactatemia is very common in patients with sepsis and septic shock and is closely associated with poor prognosis. The third international consensus definition for sepsis and septic shock recently revised the def

  7. Slide 7: Covid-19: A retrospective review of medical records in a single medical centre, Wuhan, China

    7 Covid - 19: A retrospective review of medical records in a single medical centre, Wuhan, China https://www.sciencedirect.com/science/article/pii/S1201971220301867

  8. Slide 8: Covid-19: A retrospective review of medical records in a single medical centre, Wuhan, China

    8 Covid - 19: A retrospective review of medical records in a single medical centre, Wuhan, China https://www.sciencedirect.com/science/article/pii/S1201971220301867

  9. Slide 9: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

    9 Lymphopenia predicts disease severity of COVID - 19: a descriptive and predictive study Analysis of possible reasons for lymphopenia in COVID - 19 patients - Hyperlactic acidemia / lactic acidosis inhibit lymphocytes - The severe type of COVID - 19 patients had elevated blood lactic acid levels, w

  10. Slide 10: Epidemiologic and clinical characteristics of hospitalized patients with COVID-19 in Zhejiang, China

    10 Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID - 19 in Zhejiang, China: a retrospective, multi - centre case series https://academic.oup.com/qjmed/article/113/7/474/5809152

  11. Slide 11: Conclusions

    11 Conclusions Increase in blood lactate levels is a marker of critical disease states. Recent publications have indicated the presence of elevated lactate levels in patients with Covid - 19 infection. Continuous Lactate Monitoring therefore has applications in disease states including the monitorin

Nemaura Medical — Investor Presentation (July 2020) on 6ix